Literature DB >> 1278933

Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice.

G Taylor, D Taylor-Robinson.   

Abstract

Parenteral immunization of C3H mice with viable Mycoplasma pulmonis organisms protected them from pneumonia induced by intranasal inoculation of these organisms. Spleen cells obtained from immunized mice were ineffective in preventing syngeneic recipients from developint respiratory disease. In contrast, convalescent-phase serum enhanced the clearance of mycoplasmas from the respiratory tract of mice challenged with a small number of organisms. Further, although 'immune' serum had no detectable effect on the number of mycoplasmas in the respiratory tract of mice challenged with a large number of organisms, such animals did not develop pneumonia. Since the pneumonia appears to be the results of the host's immune response to the mycoplasma, it is suggested that the transferred 'immune' serum may act by suppressing the immune response so that mice develop less severe lung lesions. This suggestion is supported by the observation that the complement-fixing antibody response of passively immunized mice was suppressed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1278933      PMCID: PMC1445060     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Authors:  G W Fernald; W A Clyde
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

2.  The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice.

Authors:  F W Denny; D Taylor-Robinson; A C Allison
Journal:  J Med Microbiol       Date:  1972-08       Impact factor: 2.472

3.  Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers.

Authors:  H Brunner; H B Greenberg; W D James; R L Horswood; R B Couch; R M Chanock
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

4.  Influence of intraperitoneal administration of hyperimmune pig serum, IgG and IgM on the development of infection in gnotobiotic piglets infected intranasally with Mycoplasma hyorhinis.

Authors:  M Gois; F Kuksa; J Franz
Journal:  Zentralbl Veterinarmed B       Date:  1974-03

5.  Mycoplasmal pneumonia of swine: active and passive immunizations.

Authors:  K M Lam; W P Switzer
Journal:  Am J Vet Res       Date:  1971-11       Impact factor: 1.156

6.  Immunity in experimentally induced enzootic pneumonia in pigs.

Authors:  R F Goodwin; R G Hodgson; P Whittlestone; R L Woodhams
Journal:  J Hyg (Lond)       Date:  1969-06

7.  Immune response of pathogen-free mice inoculated intranasally with Mycoplasma pulmonis.

Authors:  G H Cassell; J R Lindsey; H J Baker
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

8.  The antibacterial efficiencies of ovine IgA, IgM, and IgG.

Authors:  J G Knop; D Rowley
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

9.  Cell-mediated resistance to aerogenic infection of the lung.

Authors:  G L Truitt; G B Mackaness
Journal:  Am Rev Respir Dis       Date:  1971-12

10.  An attempt to transfer immunity to Mycoplasma mycoides infection with serum.

Authors:  L C Lloyd
Journal:  Bull Epizoot Dis Afr       Date:  1967-03
View more
  19 in total

Review 1.  Immunity to mycoplasma infections of the respiratory tract: a review.

Authors:  G Taylor
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 5.344

2.  Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

3.  Genetic control of resistance to Mycoplasma pulmonis infection in mice.

Authors:  W C Lai; G Linton; M Bennett; S P Pakes
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

4.  Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.

Authors:  G Taylor; C J Howard
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

5.  Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice.

Authors:  J K Davis; R F Parker; H White; D Dziedzic; G Taylor; M K Davidson; N R Cox; G H Cassell
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  Mycoplasma pulmonis infection of the murine oropharynx protects against subsequent vaginal colonization.

Authors:  P M Furr; D Taylor-Robinson
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

7.  Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B and T lymphocytes.

Authors:  Y Naot; S Merchav; E Ben-David; H Ginsburg
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

8.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 9.  The use of organ cultures and animal models in the study of Mycoplasma pneumoniae infections.

Authors:  D Taylor-Robinson
Journal:  Infection       Date:  1976       Impact factor: 3.553

10.  Effect of T-cell deficiency on the chronicity of arthritis induced in mice by Mycoplasma pulmonis.

Authors:  E C Keystone; D Taylor-Robinson; M F Osborn; L Ling; C Pope; V Fornasier
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.